Public offer to the shareholders of Elos Medtech AB – SEK 1,735 million

Carnegie acts as financial adviser to the Board of Directors of Elos Medtech in EM Intressenter’s public offer to Elos Medtech’s shareholders to tender all their shares to EM Intressenter at a price of SEK 215 in cash per share (the “Offer”). The Offer includes shares of both series A and B. The shares of series B in Elos Medtech are listed on Nasdaq Stockholm. Elos Medtech has extensive experience in product development, design of dental and orthopedic implants and other medical devices such as instruments in various types of material, primarily specialist materials such as titanium and polymer materials.
Pending.